Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lasse Evensen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|December 17, 2010
Imaged-based high-throughput screening for anti-angiogenic drug discoveryLasse Evensen, Wolfgang Link, James B Lorens
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2012
Image-based high-throughput screening for inhibitors of angiogenesisLasse Evensen, Wolfgang Link, James B Lorens
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 17, 2009
A novel imaging-based high-throughput screening approach to anti-angiogenic drug discoveryLasse Evensen, David R Micklem, Wolfgang Link, et al.
Nature Communications|March 22, 2016
Optical micromanipulation of nanoparticles and cells inside living zebrafishPatrick Lie Johansen, Federico Fenaroli, Lasse Evensen, et al.
Leukemia Research and Treatment|February 15, 2014
In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial CellsHilde Kvestad, Lasse Evensen, James B Lorens, et al.
European Journal of Haematology|October 11, 2012
Soluble mediators released by acute myeloid leukemia cells increase capillary-like networksKimberley J Hatfield, Lasse Evensen, Håkon Reikvam, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Isosteric replacement of the Z-enone with haloethyl ketone and E-enone in a resorcylic acid lactone series and biological evaluationCarmela Napolitano, Alessandro Natoni, Corrado Santocanale, et al.
Journal of Molecular Biology|March 31, 2007
The mRNA-binding site of annexin A2 resides in helices C-D of its domain IVIngvild Aukrust, Hanne Hollås, Elin Strand, et al.
Plos One|April 5, 2013
Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networksAase M Raddum, Lasse Evensen, Hanne Hollås, et al.
Journal of Molecular Biology|September 12, 2006
Engineering, biophysical characterisation and binding properties of a soluble mutant form of annexin A2 domain IV that adopts a partially folded conformationIngvild Aukrust, Lasse Evensen, Hanne Hollås, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|December 17, 2010
Imaged-based high-throughput screening for anti-angiogenic drug discoveryLasse Evensen, Wolfgang Link, James B Lorens
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2012
Image-based high-throughput screening for inhibitors of angiogenesisLasse Evensen, Wolfgang Link, James B Lorens
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 17, 2009
A novel imaging-based high-throughput screening approach to anti-angiogenic drug discoveryLasse Evensen, David R Micklem, Wolfgang Link, et al.
Nature Communications|March 22, 2016
Optical micromanipulation of nanoparticles and cells inside living zebrafishPatrick Lie Johansen, Federico Fenaroli, Lasse Evensen, et al.
Leukemia Research and Treatment|February 15, 2014
In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial CellsHilde Kvestad, Lasse Evensen, James B Lorens, et al.
European Journal of Haematology|October 11, 2012
Soluble mediators released by acute myeloid leukemia cells increase capillary-like networksKimberley J Hatfield, Lasse Evensen, Håkon Reikvam, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Isosteric replacement of the Z-enone with haloethyl ketone and E-enone in a resorcylic acid lactone series and biological evaluationCarmela Napolitano, Alessandro Natoni, Corrado Santocanale, et al.
Journal of Molecular Biology|March 31, 2007
The mRNA-binding site of annexin A2 resides in helices C-D of its domain IVIngvild Aukrust, Hanne Hollås, Elin Strand, et al.
Plos One|April 5, 2013
Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networksAase M Raddum, Lasse Evensen, Hanne Hollås, et al.
Journal of Molecular Biology|September 12, 2006
Engineering, biophysical characterisation and binding properties of a soluble mutant form of annexin A2 domain IV that adopts a partially folded conformationIngvild Aukrust, Lasse Evensen, Hanne Hollås, et al.
Pageof 2